<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>409-AMINOPENICILLINS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="AMINOPENICILLINS" code="J01CA" /></DRUG1>
<DRUG2>
<DRUG name="ALLOPURINOL" rxcui="519">
<ATC code="M04AA01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increased risk of cutaneous reactions

</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>409-AMINOPENICILLINS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="AMINOPENICILLINS" code="J01CA" /></DRUG1>
<DRUG2>
<DRUG name="MYCOPHENOLATE MOFETIL" rxcui="7145">
<ATC code="L04AA06" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the concentrations of the mycophenolic acid by about a third, with potential risk of reduction of effectiveness</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
</INTERACTIONS>
